UnitedHealth Group, US91324P1021

UnitedHealth Group Incorporated Stock (US91324P1021): Q4 and Full Year 2024 Results Scheduled for January 16, 2025

30.04.2026 - 13:25:39 | ad-hoc-news.de

UnitedHealth Group will release its fourth quarter and full year 2024 financial results on Thursday, January 16, 2025, before the market opens. The company will host a teleconference at 8:45 a.m. ET to discuss the results with analysts and investors.

UnitedHealth Group, US91324P1021
UnitedHealth Group, US91324P1021

UnitedHealth Group will release its fourth quarter and full year 2024 financial results on Thursday, January 16, 2025, before the market opens, according to the company press release.

The company will host a teleconference at 8:45 a.m. ET to discuss the results with analysts and investors, as stated in the same press release.

As of: April 30, 2026

By the AD HOC NEWS Editorial Team – Equity Coverage.

At a Glance

  • Name: UnitedHealth Group
  • ISIN: US91324P1021
  • Sector/Industry: Healthcare
  • Headquarters/Country: Eden Prairie, Minnesota, United States
  • Primary Exchange: NYSE
  • Trading Currency: USD

How UnitedHealth Group Incorporated Makes Money: The Core Business Model

UnitedHealth Group Incorporated operates as a diversified health care company with business segments including UnitedHealthcare for health insurance, Optum Health for care delivery, Optum Insight for health services, and Optum Rx for pharmacy services. The company was founded in 1974 and is headquartered in Eden Prairie, Minnesota.

UnitedHealthcare provides health benefit plans to individuals, employers, and government programs. Optum segments focus on health services, data analytics, and pharmacy benefit management.

This structure allows UnitedHealth Group to serve patients, physicians, payers, and governments across the health care system in the United States and internationally.

Official Source

Latest information on UnitedHealth Group Incorporated directly from the company's official website.

Visit Official Website

UnitedHealth Group Incorporated's Key Revenue and Product Drivers

UnitedHealthcare serves employer-sponsored, government, and individual health plans. Optum Health delivers care directly to patients through clinics and home health services.

Optum Insight provides software and consulting services to health care organizations. Optum Rx manages pharmacy benefits for health plans and employers.

These segments drive revenue through insurance premiums, care delivery fees, technology services, and pharmacy reimbursements.

Industry Trends and Competitive Landscape

The US health care industry faces trends toward value-based care, digital health integration, and rising demand from aging populations. Managed care organizations like UnitedHealth Group compete in insurance and services.

Peers in health insurance include Elevance Health and Cigna. Pharmacy benefit managers compete with CVS Health's Caremark and Express Scripts of Cigna.

Care delivery and health services face competition from Humana and regional providers.

Why UnitedHealth Group Incorporated Matters to US Investors

UnitedHealth Group Incorporated trades on the NYSE under ticker UNH in USD, providing direct exposure to the US health care sector for US investors. The company files with the SEC and is a component of major indices like the S&P 500.

With significant revenue from US government programs like Medicare and Medicaid, it offers exposure to demographic trends in the United States.

NYSE listing ensures liquidity and transparency for institutional and retail investors in the United States.

Which Investor Profile Fits UnitedHealth Group Incorporated – and Which Does Not?

Investors interested in health care sector growth, demographic tailwinds from aging populations, and diversified managed care models may find alignment with UnitedHealth Group's operations.

Those seeking exposure to insurance premiums, pharmacy benefits, and health services integration participate in its multi-segment approach.

Investors focused on high-growth tech or cyclical industries without defensive characteristics may seek alternatives.

Risks and Open Questions for UnitedHealth Group Incorporated

Regulatory changes in health care policy, such as Medicare Advantage reimbursement rates, impact profitability. Litigation related to care denial practices has drawn scrutiny.

Cybersecurity risks, including data breaches affecting millions of individuals, pose operational and financial threats.

Competition from integrated players and potential shifts in utilization patterns remain key uncertainties.

Key Events and Outlook for Investors

UnitedHealth Group has scheduled its Q4 and full year 2024 earnings release for January 16, 2025, before market open, with a conference call at 8:45 a.m. ET.

Investors monitor upcoming quarterly disclosures for updates on membership growth, medical loss ratios, and Optum performance.

What to Watch Next

  • January 16, 2025: Q4 and FY 2024 earnings release and conference call

Further Reading

Stay up to date on the latest developments, news, and analysis for this stock.

More Stock NewsInvestor Relations

Conclusion

UnitedHealth Group Incorporated has announced its fourth quarter and full year 2024 financial results release for January 16, 2025, ahead of market open, with an 8:45 a.m. ET conference call. This event provides visibility into recent performance across its insurance and Optum segments. US investors track these disclosures for insights into health care sector dynamics and company execution.

Disclaimer: This article does not constitute investment advice. Stocks are volatile financial instruments.

So schätzen die Börsenprofis UnitedHealth Group Aktien ein!

<b>So schätzen die Börsenprofis  UnitedHealth Group Aktien ein!</b>
Seit 2005 liefert der Börsenbrief trading-notes verlässliche Anlage-Empfehlungen – dreimal pro Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen. Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
Für. Immer. Kostenlos.
en | US91324P1021 | UNITEDHEALTH GROUP | boerse | 69263755 | bgmi